Changes in adhesive and migratory characteristics of hepatocellular carcinoma (HCC) cells induced by expression of alpha3beta1 integrin - PubMed (original) (raw)

. 2008 Mar;1780(3):564-70.

doi: 10.1016/j.bbagen.2007.09.007. Epub 2007 Sep 25.

Affiliations

• PMID: 17997226
• DOI: 10.1016/j.bbagen.2007.09.007

Changes in adhesive and migratory characteristics of hepatocellular carcinoma (HCC) cells induced by expression of alpha3beta1 integrin

Hiromi Mizuno et al. Biochim Biophys Acta. 2008 Mar.

Abstract

The invasive and metastatic potentials of hepatocellular carcinoma are positively correlated with the expression level of alpha3beta1 integrin, a high-affinity adhesion receptor for laminin isoforms including laminin-5. In this study, we investigated changes in the adhesive and invasive behaviors of human HCC HepG2 cells after transfection with cDNA for alpha3 integrin in order to elucidate the direct involvement of this integrin in these cellular processes. We introduced cDNA for splice variants of alpha3 integrin (alpha3A and alpha3B) into the cells, and selected two transfectant clones (HepG2-3A and HepG2-3B), which express the alpha3A and alpha3B integrins, respectively. Both transfectant cells adhered almost equally to laminin-5-coated plates in an alpha3 integrin-dependent manner, indicating that transfected alpha3Abeta1 and alpha3Bbeta1 integrins were functionally active in these cells. The migratory and invasive potentials of the transfectant cells were assessed by scratch wound assay and in vitro chemoinvasion assay. The results demonstrated that the migration of HepG2-3A and HepG2-3B cells but not of mock transfectant (HepG2-M) cells was stimulated on the plates coated with laminin-5. Furthermore, HepG2-3A and HepG2-3B cells were found to be more invasive into laminin-5-containing matrices than were HepG2-M cells. These results strongly suggest that enhanced expression of alpha3beta1 integrin on HCC cells is directly involved in their malignant phenotypes such as invasion and metastasis.

PubMed Disclaimer

Similar articles

• Transforming growth factor-beta1 upregulates transcription of alpha3 integrin gene in hepatocellular carcinoma cells via Ets-transcription factor-binding motif in the promoter region.
  Katabami K, Mizuno H, Sano R, Saito Y, Ogura M, Itoh S, Tsuji T. Katabami K, et al. Clin Exp Metastasis. 2005;22(7):539-48. doi: 10.1007/s10585-005-5260-x. Epub 2006 Feb 11. Clin Exp Metastasis. 2005. PMID: 16475024
• Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin.
  Giannelli G, Fransvea E, Marinosci F, Bergamini C, Colucci S, Schiraldi O, Antonaci S. Giannelli G, et al. Am J Pathol. 2002 Jul;161(1):183-93. doi: 10.1016/s0002-9440(10)64170-3. Am J Pathol. 2002. PMID: 12107103 Free PMC article.
• Functional comparison of the alpha3A and alpha3B cytoplasmic domain variants of the chicken alpha3 integrin subunit.
  DiPersio CM, Trevithick JE, Hynes RO. DiPersio CM, et al. Exp Cell Res. 2001 Aug 1;268(1):45-60. doi: 10.1006/excr.2001.5273. Exp Cell Res. 2001. PMID: 11461117
• Physiological and pathological roles of alpha3beta1 integrin.
  Tsuji T. Tsuji T. J Membr Biol. 2004 Aug 1;200(3):115-32. doi: 10.1007/s00232-004-0696-5. J Membr Biol. 2004. PMID: 15625821 Review.
• Integrin α3β1 as a breast cancer target.
  Subbaram S, Dipersio CM. Subbaram S, et al. Expert Opin Ther Targets. 2011 Oct;15(10):1197-210. doi: 10.1517/14728222.2011.609557. Epub 2011 Aug 13. Expert Opin Ther Targets. 2011. PMID: 21838596 Free PMC article. Review.

Cited by

• A pentacyclic triterpene natural product, ursolic acid and its prodrug US597 inhibit targets within cell adhesion pathway and prevent cancer metastasis.
  Xiang L, Chi T, Tang Q, Yang X, Ou M, Chen X, Yu X, Chen J, Ho RJ, Shao J, Jia L. Xiang L, et al. Oncotarget. 2015 Apr 20;6(11):9295-312. doi: 10.18632/oncotarget.3261. Oncotarget. 2015. PMID: 25823660 Free PMC article.
• Integrin α3 is overexpressed in glioma stem-like cells and promotes invasion.
  Nakada M, Nambu E, Furuyama N, Yoshida Y, Takino T, Hayashi Y, Sato H, Sai Y, Tsuji T, Miyamoto KI, Hirao A, Hamada JI. Nakada M, et al. Br J Cancer. 2013 Jun 25;108(12):2516-24. doi: 10.1038/bjc.2013.218. Epub 2013 May 7. Br J Cancer. 2013. PMID: 23652300 Free PMC article.
• Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin β1 in hepatocellular carcinoma.
  Zha R, Guo W, Zhang Z, Qiu Z, Wang Q, Ding J, Huang S, Chen T, Gu J, Yao M, He X. Zha R, et al. PLoS One. 2014 Feb 3;9(2):e87665. doi: 10.1371/journal.pone.0087665. eCollection 2014. PLoS One. 2014. PMID: 24498348 Free PMC article.
• Modulating the Crosstalk between the Tumor and Its Microenvironment Using RNA Interference: A Treatment Strategy for Hepatocellular Carcinoma.
  Mroweh M, Decaens T, Marche PN, Macek Jilkova Z, Clément F. Mroweh M, et al. Int J Mol Sci. 2020 Jul 24;21(15):5250. doi: 10.3390/ijms21155250. Int J Mol Sci. 2020. PMID: 32722054 Free PMC article. Review.
• hTERT mediates gastric cancer metastasis partially through the indirect targeting of ITGB1 by microRNA-29a.
  He B, Xiao YF, Tang B, Wu YY, Hu CJ, Xie R, Yang X, Yu ST, Dong H, Zhao XY, Li JL, Yang SM. He B, et al. Sci Rep. 2016 Feb 23;6:21955. doi: 10.1038/srep21955. Sci Rep. 2016. PMID: 26903137 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Medical

  • MedlinePlus Health Information